NCT06540521

Brief Summary

The purpose of this study is to investigate the cardiac electrical characteristics in different pacing outputs and body positions in LBB area pacing (LBBAP), from which the findings may help to develop and support data validation of a novel algorithm for LBB capture determination for LBBAP.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
1mo left

Started Aug 2024

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Aug 2024Jun 2026

First Submitted

Initial submission to the registry

August 1, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 6, 2024

Completed
7 days until next milestone

Study Start

First participant enrolled

August 13, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

September 29, 2025

Status Verified

September 1, 2025

Enrollment Period

1.9 years

First QC Date

August 1, 2024

Last Update Submit

September 23, 2025

Conditions

Keywords

LBBAPLBBPLVSP

Outcome Measures

Primary Outcomes (1)

  • Intracardiac electrical characteristics in different pacing outputs.

    12-lead ECG and LBBAP EGM characteristics and duration in different pacing outputs.

    received LBBAP therapy >= 1 month for 1 to 4 months (including 1 and 4 month); and an optional follow-up 6 month after the enrollment

Secondary Outcomes (2)

  • Intracardiac electrical characteristics under different body position.

    received LBBAP therapy >= 1 month for 1 to 4 months (including 1 and 4 month); and an optional follow-up 6 month after the enrollment

  • The correlation between LBB capture status and LBBAP EGM characteristics

    received LBBAP therapy >= 1 month for 1 to 4 months (including 1 and 4 month); and an optional follow-up 6 month after the enrollment

Interventions

No intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study selected two study site in China. One is a Tertiary A hospital in Shanghai, and another is a cardiovascular specialty hospital in Zhejiang Province. Both the two sites locate in the south east of China. This study will enroll 70 subjects who meet all the inclusion and exclusion criteria from the patients who have received LBBAP therapies from the two hospitals.

You may qualify if:

  • Patients aged \>=18 years
  • Patients who are willing to provide Informed Consent
  • Patients who have received LBBAP therapy \>= 1 month for 1 to 4 months (including 1 and 4 month)
  • Patients implanted with a single/dual-chamber pacemaker or a CRT-P with LBBAP lead connected to RV port
  • Implanted device can provide at least 3-channel real-time intracardiac electrogram

You may not qualify if:

  • Patients who are pregnant or have a plan for pregnancy during the study
  • Patients who have medical conditions that would limit study participation
  • Patients who were already enrolled in clinical trial(s) which would impact study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Shanghai Chest Hospital

Shanghai, Shanghai Municipality, China

RECRUITING

Zhejiang Greentown Cardiovascular Hospital

Hangzhou, Zhejiang, China

NOT YET RECRUITING

Related Publications (4)

  • Huang W, Su L, Wu S, Xu L, Xiao F, Zhou X, Ellenbogen KA. A Novel Pacing Strategy With Low and Stable Output: Pacing the Left Bundle Branch Immediately Beyond the Conduction Block. Can J Cardiol. 2017 Dec;33(12):1736.e1-1736.e3. doi: 10.1016/j.cjca.2017.09.013. Epub 2017 Sep 22.

    PMID: 29173611BACKGROUND
  • Chen X, Qian Z, Zou F, Wang Y, Zhang X, Qiu Y, Hou X, Zhou X, Vijayaraman P, Zou J. Differentiating left bundle branch pacing and left ventricular septal pacing: An algorithm based on intracardiac electrophysiology. J Cardiovasc Electrophysiol. 2022 Mar;33(3):448-457. doi: 10.1111/jce.15350. Epub 2022 Jan 12.

    PMID: 34978368BACKGROUND
  • Zhou Y, Wang J, Wei Y, Zhang W, Yang Y, Rui S, Ju C. Left ventricular septal pacing versus left bundle branch pacing in the treatment of atrioventricular block. Ann Noninvasive Electrocardiol. 2022 May;27(3):e12944. doi: 10.1111/anec.12944. Epub 2022 Mar 10.

    PMID: 35267228BACKGROUND
  • Wu S, Chen X, Wang S, Xu L, Xiao F, Huang Z, Zheng R, Jiang L, Vijayaraman P, Sharma PS, Su L, Huang W. Evaluation of the Criteria to Distinguish Left Bundle Branch Pacing From Left Ventricular Septal Pacing. JACC Clin Electrophysiol. 2021 Sep;7(9):1166-1177. doi: 10.1016/j.jacep.2021.02.018. Epub 2021 Apr 28.

    PMID: 33933414BACKGROUND

MeSH Terms

Conditions

Heart FailureBradycardia

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesArrhythmias, CardiacPathologic ProcessesPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2024

First Posted

August 6, 2024

Study Start

August 13, 2024

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

September 29, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations